Kåre Schultz, Teva CEO (Getty)
Teva execs claim mixed winning streak in pricey opioids court battle — as permanent peace remains elusive
Teva execs turned up for the Q4 call with analysts to go deep into the numbers, but it wasn’t long before the litigation around opioids …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
